Reviewer | Employment | Research Grant | Other Research Support |
Speakers’ Bureau/ Honoraria |
Expert Witness |
Ownership Interest |
Consultant/Advisory Board |
Other |
---|---|---|---|---|---|---|---|---|
Heather L. Gornik | Cleveland Clinic | None | None | None | None | None | None | FMD Society of America (volunteer, Medical Advisory Board, FMD Society of America, a nonprofit organization)* |
Roxana Mehran | Mount Sinai Medical Centre | None | None | None | None | None | None | None |
Jeffrey W. Olin | Mount Sinai School of Medicine | Philanthropy (money donated by a patient for research on FMD; looking into genetic mechanisms of FMD)† | None | None | None | None | None | Fibromuscular Dysplasia Society of America (uncompensated)* |
Jennifer Tremmel | Stanford University | None | None | None | None | None | None | None |
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
Modest.
Significant.